Details for Patent: 6,262,022
✉ Email this page to a colleague
Summary for Patent: 6,262,022
Title: | Pharmaceutical compositions containing cyclosporin as the active agent |
Abstract: | Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-, di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesterified corn oil is provided representing a mixed mono-, di- and tri-glyceride suitable for the novel formulation. Dosage forms include in particular oral dosage forms. |
Inventor(s): | Hauer; Birgit (Lahr, DE), Meinzer; Armin (Freiburg-Munzingen, DE), Posanski; Ulrich (Freiburg, DE), Vonderscher; Jacky (Riedisheim, DE) |
Assignee: | Novartis AG (Basel, CH) |
Application Number: | 09/488,215 |
Patent Claim Types: see list of patent claims | Composition; Dosage form; | More… ↓ |
Drugs Protected by US Patent 6,262,022
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,262,022
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 403436 | ⤷ Subscribe | |||
Austria | A129892 | ⤷ Subscribe | |||
Australia | 1852792 | ⤷ Subscribe | |||
Australia | 659460 | ⤷ Subscribe | |||
Canada | 2072509 | ⤷ Subscribe | |||
Canada | 2175842 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |